IL97019A - Pharmaceutical compositions containing erythropoietin and cyclodextrin - Google Patents
Pharmaceutical compositions containing erythropoietin and cyclodextrinInfo
- Publication number
- IL97019A IL97019A IL97019A IL9701991A IL97019A IL 97019 A IL97019 A IL 97019A IL 97019 A IL97019 A IL 97019A IL 9701991 A IL9701991 A IL 9701991A IL 97019 A IL97019 A IL 97019A
- Authority
- IL
- Israel
- Prior art keywords
- cyclodextrin
- pharmaceutical compositions
- compositions containing
- radical
- alk
- Prior art date
Links
- 229920000858 Cyclodextrin Polymers 0.000 title abstract 3
- 102000003951 Erythropoietin Human genes 0.000 title abstract 2
- 108090000394 Erythropoietin Proteins 0.000 title abstract 2
- 229940105423 erythropoietin Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 title abstract 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Crystallography & Structural Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Polyurethanes Or Polyureas (AREA)
- Peptides Or Proteins (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Perforating, Stamping-Out Or Severing By Means Other Than Cutting (AREA)
- Processing Of Stones Or Stones Resemblance Materials (AREA)
- Re-Forming, After-Treatment, Cutting And Transporting Of Glass Products (AREA)
- Manufacturing Of Magnetic Record Carriers (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909001987A GB9001987D0 (en) | 1990-01-29 | 1990-01-29 | Improved cyclodextrin based erythropietin formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL97019A0 IL97019A0 (en) | 1992-03-29 |
| IL97019A true IL97019A (en) | 1997-07-13 |
Family
ID=10670074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL97019A IL97019A (en) | 1990-01-29 | 1991-01-24 | Pharmaceutical compositions containing erythropoietin and cyclodextrin |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5376632A (fi) |
| EP (1) | EP0513072B1 (fi) |
| JP (1) | JP2997052B2 (fi) |
| KR (1) | KR0183445B1 (fi) |
| AT (1) | ATE107518T1 (fi) |
| AU (1) | AU648061B2 (fi) |
| CA (1) | CA2074820C (fi) |
| DE (1) | DE69102627T2 (fi) |
| DK (1) | DK0513072T3 (fi) |
| ES (1) | ES2059115T3 (fi) |
| FI (1) | FI105012B (fi) |
| GB (1) | GB9001987D0 (fi) |
| HU (1) | HU218213B (fi) |
| IE (1) | IE65209B1 (fi) |
| IL (1) | IL97019A (fi) |
| NO (1) | NO304728B1 (fi) |
| NZ (1) | NZ236938A (fi) |
| PT (1) | PT96593B (fi) |
| WO (1) | WO1991011200A1 (fi) |
| ZA (1) | ZA91620B (fi) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4126984A1 (de) * | 1991-08-15 | 1993-02-18 | Boehringer Mannheim Gmbh | Verfahren zur herstellung von humanprotein-enthaltenden, gut vertraeglichen arzneimitteln fuer infusions- oder injektionszwecke |
| US5661125A (en) * | 1992-08-06 | 1997-08-26 | Amgen, Inc. | Stable and preserved erythropoietin compositions |
| US5494901A (en) * | 1993-01-05 | 1996-02-27 | Javitt; Jonathan C. | Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent |
| IL116085A (en) * | 1994-12-16 | 1999-12-31 | Ortho Pharma Corp | Spray dried erythropoietin |
| DE19539574A1 (de) * | 1995-10-25 | 1997-04-30 | Boehringer Mannheim Gmbh | Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren |
| JP2000509374A (ja) | 1996-04-19 | 2000-07-25 | アルファ セラピュティック コーポレイション | 凍結乾燥した血液タンパク質のウイルス不活性化方法 |
| US5754937A (en) | 1996-05-15 | 1998-05-19 | Stackpole Limited | Hi-density forming process |
| AU726801B2 (en) * | 1997-03-18 | 2000-11-23 | Roche Diagnostics Gmbh | Pharmaceutical combined preparations containing erythropoietin and iron preparations |
| US6683100B2 (en) | 1999-01-19 | 2004-01-27 | Novartis Ag | Organic compounds |
| US6194181B1 (en) | 1998-02-19 | 2001-02-27 | Novartis Ag | Fermentative preparation process for and crystal forms of cytostatics |
| JP2002523475A (ja) * | 1998-09-02 | 2002-07-30 | アラーガン・セイルズ・インコーポレイテッド | 防腐したシクロデキストリン含有組成物 |
| US20040152664A1 (en) * | 1998-09-02 | 2004-08-05 | Allergan, Inc. | Prednisolone compositions |
| KR100740794B1 (ko) | 1999-04-09 | 2007-07-20 | 오르토-맥네일 파마슈티칼, 인코퍼레이티드 | 에리트로포이에틴의 약제학적 제형 |
| WO2002011753A1 (en) * | 2000-08-04 | 2002-02-14 | Chugai Seiyaku Kabushiki Kaisha | Protein injection preparations |
| US20060235366A1 (en) * | 2000-12-20 | 2006-10-19 | Fox Hollow Technologies, Inc. | Method of evaluating a treatment for vascular disease |
| US20020146409A1 (en) * | 2001-01-30 | 2002-10-10 | Herring Steven W. | Methods for stabilizing lyophilized blood proteins |
| JPWO2003006052A1 (ja) * | 2001-07-09 | 2005-02-17 | 山之内製薬株式会社 | 徐放性注射剤用組成物およびその製造方法 |
| DE10228049A1 (de) * | 2002-06-24 | 2004-01-15 | Merck Patent Gmbh | Flüssige Zubereitung enthaltend Oligopeptide |
| US7459435B2 (en) * | 2002-08-29 | 2008-12-02 | Hoffmann-La Roche Inc. | Treatment of disturbances of iron distribution |
| US7459436B2 (en) * | 2002-11-22 | 2008-12-02 | Hoffmann-La Roche Inc. | Treatment of disturbances of iron distribution |
| CA2528988C (en) | 2003-06-10 | 2012-05-01 | Lg Life Sciences Ltd. | Stable, aqueous solution of human erythropoietin, not containing serum albumin |
| EP1537876A1 (en) * | 2003-12-01 | 2005-06-08 | BioGeneriX AG | Erythropoietin solution formulation |
| US7772182B2 (en) * | 2004-08-05 | 2010-08-10 | Alza Corporation | Stable suspension formulations of erythropoietin receptor agonists |
| US20110236902A1 (en) * | 2004-12-13 | 2011-09-29 | Tyco Healthcare Group Lp | Testing a patient population having a cardiovascular condition for drug efficacy |
| US7794413B2 (en) * | 2005-04-19 | 2010-09-14 | Ev3, Inc. | Libraries and data structures of materials removed by debulking catheters |
| CU23317A1 (es) * | 2005-07-22 | 2008-10-22 | Ct De Investigacia N Y Desarro | Formulaciones nasales de eporh con bajo contenido de ã cido siã lico para el tratamiento de enfermedades del sistema nervioso central |
| MY150649A (en) | 2006-10-20 | 2014-02-14 | Icos Corp | Compositions of chk1 inhibitors |
| EP2590666B1 (en) * | 2010-07-06 | 2017-04-26 | Augustinus Bader | Topical application of erythropoietin for use in the treatment of injuries of the cornea |
| US10328152B2 (en) | 2011-06-16 | 2019-06-25 | Nayan Patel | Method for stabilization and delivery of therapeutic molecules |
| US11583584B1 (en) * | 2015-10-28 | 2023-02-21 | Coherus Biosciences, Inc. | Stable protein compositions and methods of their use |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3346123A1 (de) * | 1983-12-21 | 1985-06-27 | Janssen Pharmaceutica, N.V., Beerse | Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung |
| JPS60258125A (ja) * | 1984-06-06 | 1985-12-20 | Hayashibara Biochem Lab Inc | 蛋白性生理活性物質を含有する水溶性乾燥物 |
| JPS6191131A (ja) * | 1984-10-09 | 1986-05-09 | Chugai Pharmaceut Co Ltd | 医薬品の吸着防止方法および組成物 |
| JPS6197229A (ja) * | 1984-10-18 | 1986-05-15 | Chugai Pharmaceut Co Ltd | 安定なエリトロポエチン製剤 |
| US4920214A (en) * | 1986-04-16 | 1990-04-24 | American Maize-Products Company | Process for producing modified cyclodextrins |
| EP0308181A1 (en) * | 1987-09-14 | 1989-03-22 | Novo Nordisk A/S | Trans-mucosal delivery formulations and a method for preparation thereof |
| US5002935A (en) * | 1987-12-30 | 1991-03-26 | University Of Florida | Improvements in redox systems for brain-targeted drug delivery |
| US5997856A (en) * | 1988-10-05 | 1999-12-07 | Chiron Corporation | Method and compositions for solubilization and stabilization of polypeptides, especially proteins |
| US5068227A (en) * | 1989-01-18 | 1991-11-26 | Cyclex, Inc. | Cyclodextrins as carriers |
-
1990
- 1990-01-29 GB GB909001987A patent/GB9001987D0/en active Pending
-
1991
- 1991-01-24 IL IL97019A patent/IL97019A/xx active IP Right Grant
- 1991-01-25 DE DE69102627T patent/DE69102627T2/de not_active Revoked
- 1991-01-25 AT AT91902955T patent/ATE107518T1/de not_active IP Right Cessation
- 1991-01-25 DK DK91902955.3T patent/DK0513072T3/da active
- 1991-01-25 HU HU9202432A patent/HU218213B/hu unknown
- 1991-01-25 EP EP91902955A patent/EP0513072B1/en not_active Revoked
- 1991-01-25 CA CA002074820A patent/CA2074820C/en not_active Expired - Fee Related
- 1991-01-25 JP JP3503095A patent/JP2997052B2/ja not_active Expired - Fee Related
- 1991-01-25 ES ES91902955T patent/ES2059115T3/es not_active Expired - Lifetime
- 1991-01-25 AU AU71497/91A patent/AU648061B2/en not_active Ceased
- 1991-01-25 WO PCT/EP1991/000173 patent/WO1991011200A1/en not_active Ceased
- 1991-01-28 ZA ZA91620A patent/ZA91620B/xx unknown
- 1991-01-28 IE IE28691A patent/IE65209B1/en not_active IP Right Cessation
- 1991-01-29 PT PT96593A patent/PT96593B/pt not_active IP Right Cessation
- 1991-01-29 NZ NZ236938A patent/NZ236938A/en unknown
-
1992
- 1992-06-30 US US07/906,780 patent/US5376632A/en not_active Expired - Lifetime
- 1992-07-24 KR KR1019920701755A patent/KR0183445B1/ko not_active Expired - Fee Related
- 1992-07-28 FI FI923402A patent/FI105012B/fi not_active IP Right Cessation
- 1992-07-29 NO NO922990A patent/NO304728B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT96593A (pt) | 1991-10-15 |
| US5376632A (en) | 1994-12-27 |
| NO304728B1 (no) | 1999-02-08 |
| FI923402L (fi) | 1992-07-28 |
| FI923402A0 (fi) | 1992-07-28 |
| EP0513072A1 (en) | 1992-11-19 |
| NO922990L (no) | 1992-07-29 |
| JPH05503700A (ja) | 1993-06-17 |
| IE65209B1 (en) | 1995-10-04 |
| DE69102627D1 (de) | 1994-07-28 |
| AU648061B2 (en) | 1994-04-14 |
| ES2059115T3 (es) | 1994-11-01 |
| NZ236938A (en) | 1992-07-28 |
| AU7149791A (en) | 1991-08-21 |
| WO1991011200A1 (en) | 1991-08-08 |
| CA2074820A1 (en) | 1991-07-30 |
| HU218213B (hu) | 2000-06-28 |
| IL97019A0 (en) | 1992-03-29 |
| NO922990D0 (no) | 1992-07-29 |
| EP0513072B1 (en) | 1994-06-22 |
| KR0183445B1 (en) | 1999-05-01 |
| PT96593B (pt) | 2001-06-29 |
| ZA91620B (en) | 1992-10-28 |
| IE910286A1 (en) | 1991-07-31 |
| DK0513072T3 (da) | 1994-08-01 |
| HUT62198A (en) | 1993-04-28 |
| FI105012B (fi) | 2000-05-31 |
| DE69102627T2 (de) | 1994-11-03 |
| HU9202432D0 (en) | 1992-10-28 |
| GB9001987D0 (en) | 1990-03-28 |
| JP2997052B2 (ja) | 2000-01-11 |
| ATE107518T1 (de) | 1994-07-15 |
| CA2074820C (en) | 2003-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL97019A (en) | Pharmaceutical compositions containing erythropoietin and cyclodextrin | |
| TW374768B (en) | 8-naphthalimide derivative and processes for their manufacture | |
| TW334418B (en) | Stilbene derivatives and pharmaceutical compositions | |
| MX9803761A (es) | Nuevos agentes de transfeccion y sus aplicaciones farmaceuticas. | |
| IL118047A0 (en) | Sulfated oligosaccharides pharmaceutical compositions containing them and their use | |
| MY116624A (en) | Polymer-bound camptothecin derivatives. | |
| EP0831100A4 (en) | NEW PEPTIDE DERIVATIVES | |
| IL136044A (en) | 2-aminoacetamide derivatives and pharmaceutical compositions containing the same | |
| ATE36859T1 (de) | 4'-demethyl-4-epipodophyllotoxin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| GB2276819B (en) | Aqueous wound treatment composition comprising a polysaccharide and hexylene glycol | |
| IL117091A (en) | Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation threreof | |
| CA2040905A1 (en) | Carbohydrate derivatives comprising a trisaccharide unit | |
| GB8419737D0 (en) | Detergent compositions | |
| ATE207516T1 (de) | Wasserbeständige metallpigmente enthaltende paste und herstellungsverfahren davon | |
| EP0479465A3 (en) | Inhibition of scale | |
| BG100661A (en) | Aryl acetic acid derivatives | |
| MY120683A (en) | New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals. | |
| EP0450420A3 (en) | Dihydropyridines substituted by heterocycles, process for their preparation and their use in medicaments | |
| ES8702888A1 (es) | Procedimiento para preparar derivados de n-(adamantil-1)-pirrolidon-5-carboxamida-2. | |
| MY132057A (en) | Quinoxalinones, a process for their preparation and their use | |
| ATE166647T1 (de) | Bis-naphthalimide für die behandlung von krebs | |
| IL108856A0 (en) | Hydroxymethyl-furazancarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them | |
| MX9206116A (es) | Productos de reaccion de aminadiol y de substancia polifuncional y su aplicacion en las composiciones de pinturas cationicas electrodepositables | |
| TR199800210T2 (xx) | Didepsipeptid temelli endoparazitisid kompozisyonlar, yeni didepsipeptidler ve bunlar�n �retimi i�in i�lemler. | |
| NZ510116A (en) | Tricyclic delta-3-piperidines as pharmaceuticals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed |